Arcutis Biotherapeutics(us:ARQT)

14.73

-8.85%

Updated on 2025-04-04

Open:15.60
Close:14.73
High:16.04
Low:14.26
Prev Close:16.16
Volume:2.14M
Turnover:31.71M
Turnover Ratio:1.80%
Shares:118.64M
MarketCap:1.75B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30206126362451108.48%455981
2024-03-31181124726419107.98%565060
2023-12-31171101240218104.60%404965
2023-09-3014667019495108.34%185453
2023-06-3016171965793116.77%236557
2023-03-3115871442056116.44%226751
2022-12-3115866073309108.25%217045
2022-09-301485922532697.24%356731
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Jennison Associates Llc115716949.93%-604621-4.97%
2024-06-30Suvretta Capital Management, Llc100044928.59%212719527.00%
2024-06-30Rubric Capital Management Lp98166728.43%230667230.71%
2024-06-30Frazier Life Sciences Management, L.P.87852847.54%0
2024-06-30Blackrock Inc.86226187.40%196387729.49%
2024-06-30Polar Capital Holdings Plc68790725.91%-6850-0.10%
2024-06-30Vanguard Group Inc61442905.28%97787318.93%
2024-06-30State Street Corp51348434.41%-3649195-41.54%
2024-06-30Franklin Resources Inc44381793.81%-204281-4.40%
2024-06-30Morgan Stanley39726943.41%-33641-0.84%

About

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Address:3027 Townsgate Road,Suite 300

Market Movers